Singapore: Medicaments Containing Hormones Market 2025

Medicaments Containing Hormones Market Size in Singapore

In 2022, the Singaporean medicaments containing hormones market decreased by X% to $X for the first time since 2017, thus ending a four-year rising trend. In general, consumption, however, showed resilient growth. Over the period under review, the market reached the maximum level at $X in 2021, and then reduced rapidly in the following year.

Medicaments Containing Hormones Production in Singapore

In value terms, medicaments containing hormones production fell to $X in 2022 estimated in export price. Over the period under review, production, however, continues to indicate buoyant growth. The pace of growth was the most pronounced in 2014 with an increase of X%. Over the period under review, production attained the maximum level at $X in 2018; however, from 2019 to 2022, production remained at a lower figure.

Medicaments Containing Hormones Exports

Exports from Singapore

In 2022, overseas shipments of medicaments containing hormones but not antibiotics decreased by X% to X tons, falling for the fourth year in a row after two years of growth. Overall, exports, however, continue to indicate a significant increase. The pace of growth was the most pronounced in 2018 when exports increased by X% against the previous year. As a result, the exports reached the peak of X tons. From 2019 to 2022, the growth of the exports remained at a somewhat lower figure.

In value terms, medicaments containing hormones exports fell to $X in 2022. Over the period under review, exports, however, enjoyed a significant increase. The most prominent rate of growth was recorded in 2018 with an increase of X%. As a result, the exports attained the peak of $X. From 2019 to 2022, the growth of the exports remained at a lower figure.

Exports by Country

Malaysia (X tons) was the main destination for medicaments containing hormones exports from Singapore, with a X% share of total exports. Moreover, medicaments containing hormones exports to Malaysia exceeded the volume sent to the second major destination, the United States (X kg), more than tenfold.

From 2012 to 2022, the average annual rate of growth in terms of volume to Malaysia stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (X% per year) and Indonesia (X% per year).

In value terms, the largest markets for medicaments containing hormones exported from Singapore were Malaysia ($X), the United States ($X) and Indonesia ($X), with a combined X% share of total exports.

Among the main countries of destination, Malaysia, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average medicaments containing hormones export price stood at $X per ton in 2022, picking up by X% against the previous year. Over the last decade, it increased at an average annual rate of X%. The pace of growth appeared the most rapid in 2020 when the average export price increased by X% against the previous year. The export price peaked in 2022 and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the United States ($X per ton), while the average price for exports to Indonesia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United States (X%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Hormones Imports

Imports into Singapore

In 2022, overseas purchases of medicaments containing hormones but not antibiotics decreased by X% to X tons for the first time since 2018, thus ending a three-year rising trend. In general, imports, however, posted a significant increase. The most prominent rate of growth was recorded in 2017 with an increase of X%. Imports peaked at X tons in 2021, and then fell rapidly in the following year.

In value terms, medicaments containing hormones imports fell sharply to $X in 2022. Over the period under review, imports, however, showed a significant increase. The most prominent rate of growth was recorded in 2017 with an increase of X% against the previous year. Over the period under review, imports attained the maximum at $X in 2021, and then dropped remarkably in the following year.

Imports by Country

In 2022, the UK (X tons) was the main supplier of medicaments containing hormones to Singapore, with a X% share of total imports. It was followed by the United States (X tons), with a X% share of total imports.

From 2012 to 2022, the average annual growth rate of volume from the UK totaled X%.

In value terms, the UK ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to Singapore, comprising X% of total imports. The second position in the ranking was held by the United States ($X), with a X% share of total imports.

From 2012 to 2022, the average annual rate of growth in terms of value from the UK amounted to X%.

Import Prices by Country

In 2022, the average medicaments containing hormones import price amounted to $X per ton, surging by X% against the previous year. Over the period under review, the import price recorded a strong increase. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the UK ($X per ton), while the price for the United States stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :